tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Encompass Health narrows FY23 adjusted EPS view to $3.41-$3.52 from $3.31-$3.53

Narrows FY23 revenue view to $4.77B-$4.8B from $4.75B-$4.81B, consensus $4.79B. Raises FY23 adjusted EBITDA view to $940M-$955M from $920M-$950M.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See the top stocks recommended by analysts >>

Read More on EHC:

Disclaimer & DisclosureReport an Issue

1